Literature DB >> 17360652

Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion.

Martin Rowe1, Britt Glaunsinger, Daphne van Leeuwen, Jianmin Zuo, David Sweetman, Don Ganem, Jaap Middeldorp, Emmanuel J H J Wiertz, Maaike E Ressing.   

Abstract

Relatively little is known about immune evasion during the productive phase of infection by the gamma(1)-herpesvirus Epstein-Barr virus (EBV). The use of a unique system to isolate cells in lytic cycle allowed us to identify a host shutoff function operating in productively EBV-infected B cells. This impairment of protein synthesis results from mRNA degradation induced upon expression of the early lytic-cycle gene product BGLF5. Recently, a gamma(2)-herpesvirus, Kaposi sarcoma herpesvirus, has also been shown to encode a host shutoff function, indicating that host shutoff appears to be a general feature of gamma-herpesviruses. One of the consequences of host shutoff is a block in the synthesis of HLA class I and II molecules, reflected by reduced levels of these antigen-presenting complexes at the surface of cells in EBV lytic cycle. This effect could lead to escape from T cell recognition and elimination of EBV-producing cells, thereby allowing generation of viral progeny in the face of memory T cell responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360652      PMCID: PMC1805610          DOI: 10.1073/pnas.0611128104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection.

Authors:  Maaike E Ressing; Sinéad E Keating; Daphne van Leeuwen; Danijela Koppers-Lalic; Isabel Y Pappworth; Emmanuel J H J Wiertz; Martin Rowe
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

2.  Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis.

Authors:  L Coscoy; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

3.  Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses.

Authors:  P G Stevenson; S Efstathiou; P C Doherty; P J Lehner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

4.  The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1.

Authors:  Danijela Koppers-Lalic; Frans A M Rijsewijk; Sylvia B E Verschuren; Jacqueline A M van Gaans-van den Brink; Anne Neisig; Maaike E Ressing; Jacques Neefjes; Emmanuel J H J Wiertz
Journal:  J Gen Virol       Date:  2001-09       Impact factor: 3.891

5.  Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice.

Authors:  T J Smith; C E Ackland-Berglund; D A Leib
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain.

Authors:  B J Geiss; T J Smith; D A Leib; L A Morrison
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Site-directed mutagenesis in a conserved motif of Epstein-Barr virus DNase that is homologous to the catalytic centre of type II restriction endonucleases.

Authors:  Ming-Tsan Liu; Hsien-Ping Hu; Tsuey-Ying Hsu; Jen-Yang Chen
Journal:  J Gen Virol       Date:  2003-03       Impact factor: 3.891

8.  Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus.

Authors:  Henri Gruffat; Julien Batisse; Dagmar Pich; Bernhard Neuhierl; Evelyne Manet; Wolfgang Hammerschmidt; Alain Sergeant
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules.

Authors:  Sinéad Keating; Stuart Prince; Matthew Jones; Martin Rowe
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection.

Authors:  Andrew D Hislop; Nicola E Annels; Nancy H Gudgeon; Alison M Leese; Alan B Rickinson
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

View more
  122 in total

1.  Global analysis of the transcriptional response of whitefly to tomato yellow leaf curl China virus reveals the relationship of coevolved adaptations.

Authors:  Jun-Bo Luan; Jun-Min Li; Nélia Varela; Yong-Liang Wang; Fang-Fang Li; Yan-Yuan Bao; Chuan-Xi Zhang; Shu-Sheng Liu; Xiao-Wei Wang
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  The "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection.

Authors:  Daniëlle Horst; Wim P Burmeister; Ingrid G J Boer; Daphne van Leeuwen; Marlyse Buisson; Alexander E Gorbalenya; Emmanuel J H J Wiertz; Maaike E Ressing
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

3.  A common strategy for host RNA degradation by divergent viruses.

Authors:  Marta Maria Gaglia; Sergio Covarrubias; Wesley Wong; Britt A Glaunsinger
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

4.  Nuclear import of cytoplasmic poly(A) binding protein restricts gene expression via hyperadenylation and nuclear retention of mRNA.

Authors:  G Renuka Kumar; Britt A Glaunsinger
Journal:  Mol Cell Biol       Date:  2010-09-07       Impact factor: 4.272

5.  Evidence for translational regulation by the herpes simplex virus virion host shutoff protein.

Authors:  Holly A Saffran; G Sullivan Read; James R Smiley
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

6.  The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways.

Authors:  Jianmin Zuo; Laura L Quinn; Jennifer Tamblyn; Wendy A Thomas; Regina Feederle; Henri-Jacques Delecluse; Andrew D Hislop; Martin Rowe
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

7.  Viral manipulation of host mRNA decay.

Authors:  Liang Guo; Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Future Virol       Date:  2018-02-23       Impact factor: 1.831

Review 8.  Inflammasomes and its importance in viral infections.

Authors:  Gaurav Shrivastava; Moisés León-Juárez; Julio García-Cordero; David Eduardo Meza-Sánchez; Leticia Cedillo-Barrón
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

9.  Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.

Authors:  Manuel Albanese; Takanobu Tagawa; Mickaël Bouvet; Liridona Maliqi; Dominik Lutter; Jonathan Hoser; Maximilian Hastreiter; Mitch Hayes; Bill Sugden; Larissa Martin; Andreas Moosmann; Wolfgang Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

10.  Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.

Authors:  Eva M Campion; Roya Hakimjavadi; Sinéad T Loughran; Susan Phelan; Sinéad M Smith; Brendan N D'Souza; Rosemary J Tierney; Andrew I Bell; Paul A Cahill; Dermot Walls
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.